Marburg

Marburg

Biodefense Headlines – April 30, 2026

News Scan April 30, 2026

This week’s selections include cascading institutional disruptions reshaping U.S. public health and science governance — including the Trump administration’s mass firing of the National Science Board and restrictions on graduate…

Inhibiting PP2A-B56 to Suppress Ebola Virus Transcription and Infection

BARDA BAA 2018: Pandemic Influenza, Infectious Diseases, CBRN Countermeasures

NIAID Backs VesiculoVax Vaccine for Ebola, Marburg, and Lassa Viruses

Monoclonal Antibody Cures Late-Stage Marburg Infection in Monkeys

PHEMCE Review: Accomplishments and Future Areas of Opportunity

GAO Recommendations on Select Agent Program Improvements

Advanced Development of Filovirus and Lassa Fever Vaccines

A Lengthy Arms Race Between Ebola and Bats

USAMRIID Seeks Mouse Supply for Filovirus Research

DoD CBRN Medical Countermeasure Consortium

Handicapping Ebola to Buy Immune System Time to Respond

RFI – Vaccine Candidates and Technologies for Filoviruses

BAA – Medical Countermeasures for Priority Pathogens

New Antibody Weapons Against Marburg Virus

Airport Screening for Viruses Misses Half of Infected Travelers

Llama Antibodies Could Hold Key to Marburg, Ebola Diagnostics

Military Seeks Support for Arenaviruses Countermeasures

Qiagen to Distribute Altona Diagnostic’s Ebola Tests

First Human Trial Investigating Bavarian Nordic Filovirus Vaccine

Call for Proposals on Ebola and Other Filoviruses

Biodefense Headlines – April 30, 2026